Jonathan Douglas Finn

Title: Innovations of Jonathan Douglas Finn

Introduction

Jonathan Douglas Finn is a notable inventor based in Cambridge, MA (US). He has made significant contributions to the field of biotechnology, particularly in gene editing and therapeutic applications. With a total of 2 patents, his work has the potential to impact various medical treatments.

Latest Patents

Finn's latest patents include "Compositions and methods for expressing factor IX" and "Polynucleotides, compositions, and methods for genome editing." The first patent provides compositions and methods for expressing Factor IX in host cells, along with engineered host cells that express this important protein. The second patent focuses on gene editing techniques, offering polynucleotides that encode Cas9, which can enhance editing efficiency and reduce immunogenicity.

Career Highlights

Throughout his career, Jonathan Finn has worked with prominent companies in the biotechnology sector. He has been associated with Intellia Therapeutics, Inc. and Regeneron Pharmaceuticals, Inc., where he has contributed to groundbreaking research and development efforts.

Collaborations

Finn has collaborated with talented individuals in his field, including Hon-Ren Huang and Moitri Roy. These partnerships have fostered innovation and have been instrumental in advancing their shared research goals.

Conclusion

Jonathan Douglas Finn's contributions to biotechnology through his patents and collaborations highlight his role as a leading inventor in the field. His work continues to pave the way for advancements in gene therapy and medical treatments.